Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.880 | 4.000 | 0.120 |
Stocks | 96.120 | 96.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.537 | 14.648 |
Price to Book | 2.955 | 2.116 |
Price to Sales | 1.785 | 1.660 |
Price to Cash Flow | 13.001 | 11.747 |
Dividend Yield | 2.580 | 2.756 |
5 Years Earnings Growth | 5.244 | 8.747 |
Name | Net % | Category Average |
---|---|---|
Industrials | 55.690 | 40.019 |
Financial Services | 12.040 | 20.827 |
Healthcare | 9.240 | 9.611 |
Consumer Defensive | 8.470 | 4.517 |
Technology | 8.080 | 8.386 |
Consumer Cyclical | 6.490 | 6.424 |
Number of long holdings: 34
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Volvo B | SE0000115446 | 8.33 | 286.00 | -0.14% | |
Atlas Copco A | SE0017486889 | 6.59 | 203.1 | -0.44% | |
Hexagon B | SE0015961909 | 6.08 | 119.25 | +0.44% | |
SEB A | SE0000148884 | 5.93 | 149.00 | +1.09% | |
ASSA ABLOY B | SE0007100581 | 5.84 | 313.8 | +0.16% | |
AstraZeneca | GB0009895292 | 5.55 | 12,296.0 | -0.87% | |
Essity B | SE0009922164 | 4.97 | 272.50 | -0.26% | |
ABB | CH0012221716 | 4.88 | 49.82 | +1.01% | |
Sandvik AB | SE0000667891 | 4.61 | 239.20 | +0.46% | |
Epiroc A | SE0015658109 | 3.93 | 224.70 | +0.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 115.09B | 14.47 | 12.60 | 13.92 | ||
SE0010127894 | 54.27B | 12.37 | 9.40 | - | ||
Handelsbanken Global Tema (A1 SEK) | 42.62B | 16.08 | 10.50 | 14.00 | ||
Handelsbanken Global Tema (B1 SEK) | 42.62B | 16.08 | 10.50 | - | ||
Handelsbanken Multi Asset 50 A1 S | 32.21B | 6.86 | 3.94 | 6.05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review